Literature DB >> 2705504

Antigenicity of low molecular weight surfactant species.

D S Strayer1, T A Merritt, C Makunike, M Hallman.   

Abstract

The authors tested the antigenicity of human lung surfactant isolated from amniotic fluid. Mice and rabbits were immunized. Rabbit polyclonal antisera to these surfactant preparations were absorbed with normal human plasma proteins. Polyclonal antisera reacted with both high molecular weight (35 kd) surfactant apoprotein and to lower molecular weight species, both 18 kd and 9 kd. Mice were used to generate monoclonal antibodies to surfactant. Enzyme-linked immunosorbant assay was used to identify five monoclonal antibodies that reacted with surfactant. By Western blot analysis, all of these recognized a low molecular weight surfactant species (9 kd) that could be either SP-B or SP-C. One reacted with a 37 kd protein in the surfactant preparation, consistent with SP-A. One monoclonal antibody also recognized a higher molecular weight species (44 kd) of unknown origin. The ability of antisera and monoclonal antibodies to inhibit the functional activity of surfactant was assayed using a pulsating bubble surfactometer. Rabbit polyclonal antisera inhibited initial surface adsorption to equilibrium surface tension and increased the minimum surface tension after 1 and 5 minutes of initiation of pulsations. This inhibitory activity of the antisera was noted in divalent F(ab')2 fragments. Monovalent F(ab) fragments and control normal rabbit sera did not inhibit surfactant function in this assay. Of the anti-surfactant monoclonal antibodies that reacted with surfactant by ELISA and Western blot, three inhibited its capacity to lower surface tension on the pulsating bubble apparatus. The other two monoclonal antibodies showed no functional inhibitory activity. It is concluded that both the 35 kd SP-A and the 9 kd proteins of human surfactant are highly immunogenic and partially crossreactive. Resulting antibodies could alter the ability of surfactant to perform its physiologic function, ie, to lower surface tension.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2705504      PMCID: PMC1879782     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  23 in total

1.  Reconstitution of surfactant activity by using the 6 kDa apoprotein associated with pulmonary surfactant.

Authors:  S H Yu; F Possmayer
Journal:  Biochem J       Date:  1986-05-15       Impact factor: 3.857

2.  The role of the low-molecular weight (less than or equal to 15,000 daltons) apoproteins of pulmonary surfactant.

Authors:  Y Suzuki; T Curstedt; G Grossmann; T Kobayashi; R Nilsson; K Nohara; B Robertson
Journal:  Eur J Respir Dis       Date:  1986-11

Review 3.  Immunologic sensitization prior to birth.

Authors:  D V Cramer; H W Kunz; T J Gill
Journal:  Am J Obstet Gynecol       Date:  1974-10-10       Impact factor: 8.661

4.  Characterization and partial amino acid sequence of a low molecular weight surfactant protein.

Authors:  D S Phelps; L M Smith; H W Taeusch
Journal:  Am Rev Respir Dis       Date:  1987-05

5.  Use of human surfactant low molecular weight apoproteins in the reconstitution of surfactant biologic activity.

Authors:  S D Revak; T A Merritt; E Degryse; L Stefani; M Courtney; M Hallman; C G Cochrane
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

6.  H-2 linked Ir gene control of antibody responses to porcine insulin. I. Development of insulin-specific antibodies in some but not all nonresponder strains injected with proinsulin.

Authors:  J A Kapp; D S Strayer
Journal:  J Immunol       Date:  1978-09       Impact factor: 5.422

Review 7.  Immunologic consequences of exogenous surfactant administration.

Authors:  T A Merritt; D S Strayer; M Hallman; R D Spragg; P Wozniak
Journal:  Semin Perinatol       Date:  1988-07       Impact factor: 3.300

8.  Isolation of a cDNA clone encoding a high molecular weight precursor to a 6-kDa pulmonary surfactant-associated protein.

Authors:  K A Jacobs; D S Phelps; R Steinbrink; J Fisch; R Kriz; L Mitsock; J P Dougherty; H W Taeusch; J Floros
Journal:  J Biol Chem       Date:  1987-07-15       Impact factor: 5.157

9.  Two hydrophobic low-molecular-mass protein fractions of pulmonary surfactant. Characterization and biophysical activity.

Authors:  T Curstedt; H Jörnvall; B Robertson; T Bergman; P Berggren
Journal:  Eur J Biochem       Date:  1987-10-15

10.  Development of gamma G, gamma A, gamma M, beta IC-beta IA, C 1 esterase inhibitor, ceruloplasmin, transferrin, hemopexin, haptoglobin, fibrinogen, plasminogen, alpha 1-antitrypsin, orosomucoid, beta-lipoprotein, alpha 2-macroglobulin, and prealbumin in the human conceptus.

Authors:  D Gitlin; A Biasucci
Journal:  J Clin Invest       Date:  1969-08       Impact factor: 14.808

View more
  3 in total

1.  A 2-year follow up of babies enrolled in a European multicentre trial of porcine surfactant replacement for severe neonatal respiratory distress syndrome. Collaborative European Multicentre Study Group.

Authors:  B Robertson; T Curstedt; R Tubman; D Strayer; P Berggren; J Kok; J Koppe; L van Sonderen; H Halliday; G McClure
Journal:  Eur J Pediatr       Date:  1992-05       Impact factor: 3.183

2.  Immunogenicity of surfactant. I. Human alveolar surfactant.

Authors:  D S Strayer; M Hallman; T A Merritt
Journal:  Clin Exp Immunol       Date:  1991-01       Impact factor: 4.330

3.  Immunogenicity of surfactant. II. Porcine and bovine surfactants.

Authors:  D S Strayer; M Hallman; T A Merritt
Journal:  Clin Exp Immunol       Date:  1991-01       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.